Challenges in the management of otitis media

American Journal of Managed Care

Volumn 5, Issue 11 SUPPL., 1999, Pages

  Pelton, Stephen I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; PENICILLIN G;

ANTIBIOTIC THERAPY; CIGARETTE SMOKING; CONFERENCE PAPER; DAY CARE; MIDDLE EAR EFFUSION; ONSET AGE; OTITIS MEDIA; PATHOPHYSIOLOGY; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SECRETORY OTITIS MEDIA; SEX DIFFERENCE;

EID: 0032884412     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Teele DW, Klein JO, Rosner BA, and the Greater Boston Otitis Media Study Group. Otitis media with effusion during the first three years of life and development of speech and language. Pediatrics 1984; 74:282-287.
2. Schappert SM. Office visits for otitis media: United States, 1975-90. Hyattsville, MD: Vital and Health Statistics. National Center for Health Statistics. Centers for Disease Control. US Department of Health and Human Services. 1992; Advance Data No. 214:1-18.
3. Karma PH, Sipilä MM, Kataja MJ, Penttilä MA. Pneumatic otoscopy and otitis media. II. Value of different tympanic membrane findings and their combinations. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, Ogra PL, eds. Recent Advances in Otitis Media. Proceedings of the Fifth International Symposium. Burlington, Ontario, Canada: Decker;1993:41-45.
4. Kontiokari T, Koivunen P, Niemelä M, Pokka T, Uhari M. Symptoms of acute otitis media. Pediatr Infect Dis J 1998;17:676-679.
5. Howie VM, Ploussard JH, Lester RL Jr. Otitis media: A clinical and bacteriological correlation. Pediatrics 1970;45:29-35.
6. Teele DW, Klein JO, Rosner BA, and the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective, cohort study. J Infect Dis 1989;160:83-94.
7. Thomson M. Otitis media: How are First Nations children affected? Can Fam Physician 1994;40:1943-1950.
8. Harris SB, Glazier R, Eng K, McMurray L. Disease patterns among Canadian aboriginal children. Can Fam Physician 1998; 44:1869-1877.
9. Tower EA. Chronic otitis media in Alaskan natives: 1954-1979: An historical perspective. Alaska Med 1979;21:48-52.
10. Christensen R. Health problems among Alaska Eskimo infants and young children. Arct Med Res 1990;49:63-67.
11. Thomas DP, Heller RF, Hunt JM. Clinical consultations in an Aboriginal community-controlled health service: A comparison with general practice. Aust N Z J Public Health 1998;22:86-91.
12. Klein JO, Bluestone CD. Management of otitis media in the era of managed care. Adv Pediatr Infect Dis 1996;12:351-386.
13. Paradise JL, Rockette HE, Colborn K, et al. Otitis media in 2253 Pittsburgh-area infants: Prevalence and risk factors during the first two years of life. Pediatrics 1997;99: 318-333.
14. DiFranza JR, Lew RA. Morbidity and mortality in children associated with the use of tobacco products by other people. Pediatrics 1996;97:560-568.
15. Etzel RA, Balk SJ, Bearer CF, et al. Environmental tobacco smoke: A hazard to children. Pediatrics 1997;99:639-642.
16. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 1997;175:1440-1445.
17. Wald ER, Dashefsky B, Byers C, Guerra N, Taylor F. Frequency and severity of infections in day care. J Pediatrics 1988;112:540-546.
18. Giebink GS. Vaccination against middle-ear bacterial and viral pathogens. Ann N Y Acad Sci 1997;830:330-352.
19. Hoberman A, Paradise JL, Block S, et al. Efficacy of amoxicillin/clavulanate for acute otitis media: Relationship to Streptococcus pneumoniae susceptibility. Pediatr Infect Dis J 1996;15:955-962.
20. Bluestone CD, Klein JO. Otitis Media in Infants and Children, 2nd ed. Philadelphia, PA: WB Saunders;1995:56:147-240.
21. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-759.
22. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The "Pollyanna phenomenon." J Pediatr 1992;120:72-77.
23. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993;12:973-975.
24. Pankuch GA, Jacobs MR, Appelbaum PC. Comparative activity of ampicillin, amoxicillin, amoxicillin/clavulanate and cefotaxime against 189 penicillin-susceptible and resistant pneumococci. J Antimicrob Chemother 1995;35:883-888.
25. Seikel K, Shelton S, McCracken GH Jr. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J 1998;17:969-970.
26. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: Results of a randomized clinical trial. Pediatrics 1991;87:466-474.
27. Sorensen H. Antibiotics in suppurative otitis media. Otolaryngologic Clin North Am 1977;10:45-50.
28. Kenna MA. Incidence and prevalence of complications of otitis media. Ann Otol Rhinol Laryngol 1990;149(suppl):38-39.
29. Cohen R, Levy C, Boucherat M, Langue J, de La Rocque F. A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr 1998;133:634-639.
30. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin®) for treatment of acute otitis media in children. Pediatr Infect Dis J 1997;16:463-470.
31. Pelton SI. New concepts in the pathophysiology and management of middle ear disease in childhood. Drugs 1996;52(suppl 2):62-66.
32. 197 in United States infants. Pediatrics 1998;101:604-611.
33. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of the Northern California Kaiser Permanente Efficacy Trial. Pediatr Res 1999;45:157A.